Southwest Gas (SWX) Q3 Earnings and Revenues Lag Estimates — Negative
SWX Zacks Investment Research — November 05, 2025Southwest Gas (SWX) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.09 per share a year ago.
Sonos (SONO) Reports Q4 Loss, Tops Revenue Estimates — Negative
SONO Zacks Investment Research — November 05, 2025Sonos (SONO) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of $0.05. This compares to a loss of $0.18 per share a year ago.
For Amazon, Microsoft and other Seattle tech firms, it's AI and anxiety — Negative
AMZN MSFT TechXplore — November 05, 2025In little more than five months, Amazon and Microsoft have announced they're collectively cutting more than 29,000 roles.
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with the Schall Law Firm — Neutral
QURE GlobeNewsWire — November 05, 2025LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) for violations of the securities laws.
Samuel Adams Unwraps Winter White Ale First New Winter Seasonal in 30 Years — Neutral
SAM GlobeNewsWire — November 05, 2025BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Samuel Adams, one of the pioneers of craft beer, is gifting drinkers its first new winter seasonal in 30 years with the release of Winter White Ale. Samuel Adams Winter White Ale-- a festive white ale brewed with orange peel, cinnamon, nutmeg, and clove, perfect for cozy nights, holiday feasts and everything in between -- is now available nationwide through January 2026.
Synopsys, Inc. (SNPS) Faces Securities Class Action Amid Q325 Results Revealing IP Business Problems -- Hagens Berman — Neutral
SNPS GlobeNewsWire — November 05, 2025SAN FRANCISCO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- A securities fraud class action, styled Kim v. Synopsys, Inc., et al.
McDonald's reports mixed 3Q results with US sales ahead of expectations — Positive
MCD Proactive Investors — November 05, 2025McDonald's Corp (NYSE:MCD, ETR:MDO) reported third-quarter earnings that slightly missed Wall Street expectations on revenue and adjusted earnings per share but saw modest strength in US same-store sales, sending shares up 3.3% in early trading on Wednesday. The fast-food giant posted revenue of $7.08 billion for the quarter, up 3% from a year ago but below the $7.10 billion analysts had expected.
Shares of Pinterest (PINS) plunged after the visual social media and search company missed profit expectations and gave weak holiday quarter guidance.
ICF International Stock Declines 5.6% Since Q3 Earnings Miss — Negative
ICFI Zacks Investment Research — November 05, 2025ICFI posts weaker third-quarter 2025 results, with earnings and revenues falling short of estimates and declining year over year.
Bet on 5 Top-Ranked Stocks With Rising P/E — Positive
BSX CHEF CRMD HNST LTH Zacks Investment Research — November 05, 2025Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include The Chef's Warehouse, Life Time Group Holdings, The Honest Company, CorMedix and Boston Scientific.
Atlanta Braves Holdings, Inc. (BATRA) Q3 Earnings Surpass Estimates — Positive
BATRA Zacks Investment Research — November 05, 2025Atlanta Braves Holdings, Inc. (BATRA) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.16 per share a year ago.
Unveiling Solventum (SOLV) Q3 Outlook: Wall Street Estimates for Key Metrics — Neutral
SOLV Zacks Investment Research — November 05, 2025Get a deeper insight into the potential performance of Solventum (SOLV) for the quarter ended September 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Atlanta Braves Holdings (BATRK) Beats Q3 Earnings Estimates — Positive
BATRK Zacks Investment Research — November 05, 2025Atlanta Braves Holdings (BATRK) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.16 per share a year ago.
Insights Into Shift4 Payments (FOUR) Q3: Wall Street Projections for Key Metrics — Positive
FOUR Zacks Investment Research — November 05, 2025Besides Wall Street's top-and-bottom-line estimates for Shift4 Payments (FOUR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Beats Revenue Estimates — Neutral
ESTA Zacks Investment Research — November 05, 2025Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.59 per share a year ago.
Great Lakes Dredge & Dock Corporation (GLDD) Hit a 52 Week High, Can the Run Continue? — Positive
GLDD Zacks Investment Research — November 05, 2025Great Lakes Dredge & Dock (GLDD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
MannKind (MNKD) Tops Q3 Earnings and Revenue Estimates — Positive
MNKD Zacks Investment Research — November 05, 2025MannKind (MNKD) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.04 per share a year ago.
Unlocking Q3 Potential of Main Street Capital (MAIN): Exploring Wall Street Estimates for Key Metrics — Positive
MAIN Zacks Investment Research — November 05, 2025Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Main Street Capital (MAIN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.
NewAmsterdam Pharma Company N.V. (NAMS) Reports Q3 Loss, Lags Revenue Estimates — Negative
NAMS Zacks Investment Research — November 05, 2025NewAmsterdam Pharma Company N.V. (NAMS) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.38.
Unlocking Q3 Potential of Paramount Skydance (PSKY): Exploring Wall Street Estimates for Key Metrics — Positive
PSKY Zacks Investment Research — November 05, 2025Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Paramount Skydance (PSKY), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.